vs
Side-by-side financial comparison of HAWTHORN BANCSHARES, INC. (HWBK) and Spero Therapeutics, Inc. (SPRO). Click either name above to swap in a different company.
HAWTHORN BANCSHARES, INC. is the larger business by last-quarter revenue ($21.2M vs $12.6M, roughly 1.7× Spero Therapeutics, Inc.). On growth, Spero Therapeutics, Inc. posted the faster year-over-year revenue change (24080.8% vs 12.2%). Over the past eight quarters, Spero Therapeutics, Inc.'s revenue compounded faster (847.7% CAGR vs 9.1%).
Hawthorn Bancshares, Inc. is a U.S. regional bank holding company operating through its wholly owned subsidiary Hawthorn Bank. It provides a full range of retail and commercial banking services including deposit products, mortgage loans, small business financing, commercial lending, and wealth management solutions, primarily serving individual customers and small to mid-sized enterprises across local communities in Missouri.
HWBK vs SPRO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $21.2M | $12.6M |
| Net Profit | — | $31.5M |
| Gross Margin | — | — |
| Operating Margin | 35.7% | — |
| Net Margin | — | 250.7% |
| Revenue YoY | 12.2% | 24080.8% |
| Net Profit YoY | — | 250.9% |
| EPS (diluted) | $0.90 | $0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $21.2M | $12.6M | ||
| Q3 25 | $20.6M | $0 | ||
| Q2 25 | $19.7M | $0 | ||
| Q1 25 | $18.8M | $12.0K | ||
| Q4 24 | $18.9M | $52.0K | ||
| Q3 24 | $18.1M | $65.0K | ||
| Q2 24 | $18.2M | $114.0K | ||
| Q1 24 | $17.8M | $140.0K |
| Q4 25 | — | $31.5M | ||
| Q3 25 | $6.1M | $-7.4M | ||
| Q2 25 | $6.1M | $-1.7M | ||
| Q1 25 | $5.4M | $-13.9M | ||
| Q4 24 | — | — | ||
| Q3 24 | $4.6M | $-17.1M | ||
| Q2 24 | $4.6M | $-17.9M | ||
| Q1 24 | $4.5M | $-12.7M |
| Q4 25 | 35.7% | — | ||
| Q3 25 | 36.4% | — | ||
| Q2 25 | 37.9% | — | ||
| Q1 25 | 35.2% | -122758.3% | ||
| Q4 24 | 29.9% | — | ||
| Q3 24 | 31.1% | -28604.6% | ||
| Q2 24 | 31.2% | -16720.2% | ||
| Q1 24 | 30.5% | -9987.1% |
| Q4 25 | — | 250.7% | ||
| Q3 25 | 29.8% | — | ||
| Q2 25 | 31.0% | — | ||
| Q1 25 | 28.7% | -115550.0% | ||
| Q4 24 | — | — | ||
| Q3 24 | 25.3% | -26380.0% | ||
| Q2 24 | 25.5% | -15668.4% | ||
| Q1 24 | 25.1% | -9049.3% |
| Q4 25 | $0.90 | $0.56 | ||
| Q3 25 | $0.88 | $-0.13 | ||
| Q2 25 | $0.88 | $-0.03 | ||
| Q1 25 | $0.77 | $-0.25 | ||
| Q4 24 | $0.66 | — | ||
| Q3 24 | $0.66 | $-0.32 | ||
| Q2 24 | $0.66 | $-0.33 | ||
| Q1 24 | $0.63 | $-0.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $104.3M | $40.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $174.2M | $59.0M |
| Total Assets | $1.9B | $68.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $104.3M | $40.3M | ||
| Q3 25 | $99.9M | $48.6M | ||
| Q2 25 | $100.3M | $31.2M | ||
| Q1 25 | $102.3M | $48.9M | ||
| Q4 24 | $51.0M | $52.9M | ||
| Q3 24 | $54.2M | $76.3M | ||
| Q2 24 | $75.8M | $63.5M | ||
| Q1 24 | $43.5M | $82.3M |
| Q4 25 | $174.2M | $59.0M | ||
| Q3 25 | $164.9M | $26.5M | ||
| Q2 25 | $156.8M | $32.8M | ||
| Q1 25 | $153.4M | $33.8M | ||
| Q4 24 | $149.5M | $46.1M | ||
| Q3 24 | $146.5M | $65.5M | ||
| Q2 24 | $138.2M | $80.5M | ||
| Q1 24 | $136.6M | $96.2M |
| Q4 25 | $1.9B | $68.9M | ||
| Q3 25 | $1.9B | $54.2M | ||
| Q2 25 | $1.9B | $62.1M | ||
| Q1 25 | $1.9B | $77.7M | ||
| Q4 24 | $1.8B | $110.5M | ||
| Q3 24 | $1.8B | $135.2M | ||
| Q2 24 | $1.8B | $149.9M | ||
| Q1 24 | $1.8B | $167.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $26.9M | $-8.4M |
| Free Cash FlowOCF − Capex | $22.8M | — |
| FCF MarginFCF / Revenue | 107.9% | — |
| Capex IntensityCapex / Revenue | 19.3% | — |
| Cash ConversionOCF / Net Profit | — | -0.26× |
| TTM Free Cash FlowTrailing 4 quarters | $32.7M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $26.9M | $-8.4M | ||
| Q3 25 | $288.0K | $17.4M | ||
| Q2 25 | $5.8M | $-17.7M | ||
| Q1 25 | $5.7M | $-4.0M | ||
| Q4 24 | $25.6M | $-23.4M | ||
| Q3 24 | $9.1M | $12.8M | ||
| Q2 24 | $8.9M | $-18.7M | ||
| Q1 24 | $5.6M | $5.9M |
| Q4 25 | $22.8M | — | ||
| Q3 25 | $-734.0K | — | ||
| Q2 25 | $5.1M | — | ||
| Q1 25 | $5.5M | — | ||
| Q4 24 | $22.6M | — | ||
| Q3 24 | $8.1M | — | ||
| Q2 24 | $8.4M | — | ||
| Q1 24 | $5.1M | — |
| Q4 25 | 107.9% | — | ||
| Q3 25 | -3.6% | — | ||
| Q2 25 | 25.9% | — | ||
| Q1 25 | 29.1% | — | ||
| Q4 24 | 119.7% | — | ||
| Q3 24 | 44.9% | — | ||
| Q2 24 | 46.2% | — | ||
| Q1 24 | 28.5% | — |
| Q4 25 | 19.3% | — | ||
| Q3 25 | 5.0% | — | ||
| Q2 25 | 3.3% | — | ||
| Q1 25 | 1.5% | — | ||
| Q4 24 | 15.9% | — | ||
| Q3 24 | 5.5% | — | ||
| Q2 24 | 3.0% | — | ||
| Q1 24 | 3.1% | — |
| Q4 25 | — | -0.26× | ||
| Q3 25 | 0.05× | — | ||
| Q2 25 | 0.94× | — | ||
| Q1 25 | 1.07× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.99× | — | ||
| Q2 24 | 1.93× | — | ||
| Q1 24 | 1.26× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
